About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Depression Clinical Trials | 3,203 Studies Recruiting

Clinical TrialsDepression

Depression Clinical Trials

Browse 3,203 clinical trials for depression. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2001-2020 of 3,203 trials

WithdrawnRandomized, Placebo-controlled Trial of an AMPAkine in Major Depressive DisorderThe purpose of this study is to test a candidate drug, Org 24448,in a phase II clinical trial in adult patients with moderately treatment-resistant unipolar major depressive…NCT00262665 CompletedMotivational Interviews for Depression in Primary CareThe purpose of the study is to determine whether motivational interviewing with guideline-based medical management for depression will significantly improve time to depression…NCT01114334·Denver, Colorado CompletedEffects of a Single Dose of Amisulpride on Functional Brain ChangesThis study is designed to investigate effects of a single dose of amisulpride on functional brain changes during reward- and motivation-related processing and at rest in healthy…NCT05347199·Berlin TerminatedPromoting Enhanced Pharmacotherapy Choice Through Immunomarkers Evaluation in DepressionPRECISE-D is a single site, randomized, open label 8-week clinical trial that will enroll 70 participants to evaluate if the level of inflammation in our body can predict how we…NCT03993457·Dallas, Texas

Related Searches

major depressivetrials mddtrials

Data from ClinicalTrials.govTerms

TerminatedAntidepressant Effects of TS-161 in Treatment-Resistant DepressionBackground: Major depressive disorder (MDD) is a common, chronic mental illness. It can take weeks to months for antidepressants to work.NCT04821271·Bethesda, Maryland

UnknownClinical Validation of a Combinatorial Pharmacogenomic Approach in Major Depressive DisorderMajor depressive disorder (MDD) is a common, chronic, debilitating mood disorder causing serious functional impairment and significantly decreased quality of life.NCT04615234·Brescia, BS

RecruitingClinical Efficacy, Safety, and Applicability of Home-based Bright Light Therapy in Outpatient Adolescents With Major Depressive DisorderMajor Depressive Disorder (MDD) is a chronic disease characterized by a high prevalence, low cure rate, and significant disability.NCT06913309·Beijing, Beijing Municipality and 2 others

Active not recruitingA Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy SubjectsThe two products used in this study are transdermal patches that contain selegiline. The test drug is the Selegiline Transdermal Delivery System (TDS).NCT07452692·Elin Pelin and 2 others

CompletedEffectsOfTranscranialPulseStimulationOnDepression-PilotRCTThe aim of this study is to evaluate the effects of transranial pulse stimulation (TPS) on young adults with symptoms of depression in Hong Kong.NCT05006365·Hong Kong

UnknownHypersomnia in Major Depressive DisorderBackground: MDD is a common mental disorder with significant morbidities and mortalities.NCT04006834·Hong Kong

CompletedNeural Predictors and Longitudinal Neural Correlates of Deep Transcranial Magnetic Stimulation for Treating Major DepressionStandard high frequency repetitive transcranial magnetic stimulation (HF-TMS) is a noninvasive method to activate or de-activate neurons in superficial regions of the brain…NCT01409317·Montreal, Quebec

CompletedZuranolone Pharmacokinetics (PK) and Safety Study Adolescent Participants With Major Depressive Disorder (MDD)The primary purpose of this study is to evaluate the pharmacokinetics and safety of Zuranolone in adolescents (ages 12 to 17 years) with MDD.NCT05655507·Atlanta, Georgia and 3 others

RecruitingInvestigating the Impacts of Early Life Experience on the Brain & BehaviourThe aim of this study is to learn more about how early life experience influences the brain, behaviour, and the immune system later in life.NCT06823492·Manchester

CompletedGW117 ODT （Orally Disintegrating Tablets） Safety and Pharmacokinetics Study in Healthy SubjectsTo evaluate the safety, tolerability and pharmacokinetics of single and multiple ascending doses of GW117 ODT in healthy volunteersNCT06964711·Beijing, Beijing Municipality

Active not recruitingCombination of Novel Therapies for CKD Comorbid DepressionThe overall goal of the study is to determine if treatment of a Major Depressive Disorder (MDD) improves the outcomes of patients with chronic kidney disease (CKD).NCT04422652·Stony Brook, New York and 3 others

CompletedA Study of LY2216684 in Healthy ParticipantsThis study will evaluate the pharmacodynamic and pharmacokinetic interaction of LY2216684 with alcohol in healthy participants. This study will run approximately for 34 days.NCT01380691·Evansville, Indiana

Not yet recruitingMental Health Mission Mood Disorder Cohort StudyThe current study aims to understand why some people with depression respond to treatment and others do not, using markers of clinical symptoms, both clinician reported outcome…NCT07189689·Oxford

TerminatedTreatment for Chronic DepressionThe purpose of this study is to test the clinical efficacy of two psychotherapies for early onset chronic major depression, including Behavioral Activation (Jacobson et al.…NCT00204152·Chicago, Illinois

CompletedZelquistinel in the Treatment of Adults With Major Depressive DisorderThe purpose of this study is to evaluate the efficacy and safety of AGN-241751 in participants with Major Depressive DisorderNCT03726658·Phoenix, Arizona and 4 others

CompletedTranslational Investigation of Gestational Environment on Neurobehavioral Function in ChildrenAlthough the last decade has brought major advances with respect to our knowledge of certain risks associated with fetal exposure to psychiatric medications, critical information…NCT02715778·Boston, Massachusetts and 1 other

PreviousPage 101 of 161Next